Blood
Pressure - Target BP is <130/<80. Additional protection
against complications, including renal failure and cardiovascular disease, may be obtained by lowering BP
further.
Weight
- Compare with measurements from prior visits to identify trends.
Blood Glucose
- Results of lab determinations and self-monitoring should be available for
timely discussion with the patient. Hemoglobin
A1c (A1C) is the "gold standard" for assessing glucose control. This test should be conducted at least twice a year in each
patient and ideally at 3-4 month intervals.
| l | Fasting/post-prandial glucose measurement and self-monitoring records should be available for timely discussion with the patient at each visit. Self-monitoring BG records are vital to diabetes management decisions. | |
| l | Assess glycemic control by reviewing A1C results determined within the past 3-4 months. Acceptable glycemic control is < 7.0%. A1C estimates the average degree of glycemic control over the preceding 3 months. A1C is the standard way to measure glycemic control. | |
| l | HbA1c results should be discussed with the patient at the time of the patient visit. If in-house measurement is unavailable, blood sample should be obtained several days before the clinic visit. |
At
each clinic visit, the appropriate education, intervention, referral, and or
follow-up will be provided as indicated.
Foot
Inspection - Inspection of feet and
nails. Check for ingrown toenails, calluses, deformities, pressure points,
ulcers, and cellulitis.